Nifedipine/Ketoprofen

硝苯地平/酮洛芬

Report date: 2022/03/04 15:54:54

Base Information

Drug NameNifedipine/Ketoprofen
Drug Alias NameNifedipine•Ketoprofen硝苯地平和酮洛芬Nifedipine-Ketoprofen mixt酮洛芬/硝苯地平硝苯地平+酮洛芬 +[12] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors +[4] 
TargetsCyclooxygenase-2Voltage-gated calcium channelCyclooxygenase-1 +[4] 
Therapy Area/IndicationsPainInflammationMuscle Spasticity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes NifedipineKetoprofen
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOmeros Corp
China Registration ClassN/A

Develop Information

Active CompaniesOmeros Corp
Inactive CompaniesN/A
Active IndicationsPainInflammationMuscle Spasticity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A